Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery
Phase 4
Withdrawn
- Conditions
- Nail Diseases
- Registration Number
- NCT04384679
- Lead Sponsor
- Weill Medical College of Cornell University
- Brief Summary
The purpose of this study is to assess the efficacy and safety of topical hemostatic powder containing hydrophilic polymer with potassium ferrate for bleeding control after nail surgical procedures
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- At least 18 years old
- Patients scheduled for any type of nail surgical procedure
- Willingness to participate in the study
- Ability to understand all instructions in the English language
Exclusion Criteria
- Failure to have nail surgery performed
- Likely inability to comply with the study protocol or cooperate fully with the research team
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Time (in seconds) to bleeding cessation with hydrophilic polymer and potassium ferrate; time (in seconds) to bleeding cessation with direct pressure with sterile gauze Baseline Time (in seconds) will be measured from application of intervention/nonintervention until bleeding cessation
- Secondary Outcome Measures
Name Time Method Number of participants with at least one adverse event End of study (28 days) Adverse events will only include those that are determined to be related to the study device
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the hemostatic effect of hydrophilic polymer and potassium ferrate in nail surgery?
How does the efficacy of hydrophilic polymer and potassium ferrate powder compare to standard-of-care hemostatic agents in nail surgery?
Are there specific biomarkers that predict optimal patient response to topical hemostatic agents containing potassium ferrate?
What are the known adverse events associated with potassium ferrate-based hemostatic powders and how are they managed clinically?
What other hemostatic compounds or combination therapies are being developed for post-surgical bleeding in dermatologic procedures?
Trial Locations
- Locations (1)
Weill Cornell Medicine
🇺🇸New York, New York, United States
Weill Cornell Medicine🇺🇸New York, New York, United States